Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Shana E Gleeson"'
Autor:
Shana E Gleeson, Heidi Zapata, Meghan E Bathgate, Brinda Emu, Jennifer Frederick, Gerald Friedland, Marjorie P Golden, Jaimie P Meyer, Joanna Radin, Robert Sideleau, Albert Shaw, Sheela V Shenoi, Paul A Trubin, Michael Virata, Lydia A Barakat, Mahalia S Desruisseaux
Publikováno v:
Clinical Infectious Diseases.
In response to longstanding healthcare inequities unmasked by the COVID-19 pandemic, the Infectious Diseases Section at the Yale School of Medicine designed and implemented a pilot curriculum integrating Diversity, Equity, and Anti-racism (ID2EA) int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae55bc88c0a25825454a9cedc1439ebc
https://doi.org/10.1093/cid/ciad236
https://doi.org/10.1093/cid/ciad236
Autor:
Alan Koff, Sanjay Kulkarni, Ousmane H. Cissé, Liang Ma, Marwan M. Azar, Kristen D Belfield, Joseph A. Kovacs, Shana E. Gleeson, Maricar Malinis, William S. Asch, Shelly Curran, Yanhong Deng, Jeffrey E Topal, Matthew Grant, Elizabeth Cohen, David C. Gaston, Geliang Gan
Publikováno v:
Clin Infect Dis
Background Pneumocystis jirovecii is an opportunistic fungus that causes Pneumocystis pneumonia (PCP) in immunocompromised hosts. Over an 11-month period, we observed a rise in cases of PCP among kidney-transplant recipients (KTR), prompting an outbr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0960e33a3e66344b16890a15b705aef1
https://doi.org/10.1093/cid/ciab474
https://doi.org/10.1093/cid/ciab474
Autor:
Sanjay Kulkarni, Jeffrey E Topal, Alan Koff, David C. Gaston, William S. Asch, Liang Ma, Kristen D Belfield, Matthew Grant, Maricar Malinis, Joseph A. Kovacs, Ousmane H. Cissé, Geliang Gan, Shana E. Gleeson, Marwan M. Azar, Elizabeth Cohen, Shelly Curran, Yanhong Deng
Publikováno v:
SSRN Electronic Journal.
Background: Pneumocystis jiroveciii is an opportunistic fungus that causes Pneumocystis pneumonia (PCP) in immunocompromised hosts. Over an 11-month period, we observed a rise in cases of PCP among kidney-transplant recipients (KTR), prompting an out
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01526098c2913ac8b9d3b923ba7a728e
https://doi.org/10.2139/ssrn.3804796
https://doi.org/10.2139/ssrn.3804796
Autor:
Matthew A. Davis, Marwan M. Azar, Alfred Ian Lee, Merceditas Villanueva, Jeffrey E Topal, Patricia LoRusso, Stuart Seropian, Insoo Kang, Frederick L. Altice, Christina Price, Alan Koff, Lauren Pischel, Sheau-Chiann Chen, Zachary Harris, Charles S. Dela Cruz, Trisha Burrello, Geoffrey L. Chupp, Shana E. Gleeson, Naftali Kaminski, Kelsey Kaman, Clemente J. Britto, Veronica Azmy, Lydia Aoun-Barakat, David C. Gaston, Dayna McManus, Richard Bucala, Yu Shyr, Maricar Malinis, George Goshua
Publikováno v:
Chest
Background Tocilizumab, an IL-6 receptor antagonist, can be used to treat cytokine release syndrome (CRS), with observed improvements in a coronavirus disease 2019 (COVID-19) case series. Research Question The goal of this study was to determine if t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::911cab5aa038680664bf07556070fdf6
Autor:
William S. Asch, Shana E. Gleeson, Sharon Klarman, Divyanshu Malhotra, Elizabeth Cohen, Gianna Girone, Sarthak Virmani
Publikováno v:
Transplantation Proceedings
The high morbidity and mortality of COVID-19 in immunocompetent patients raises significant concern for immunosuppressed kidney transplant recipients (KTRs). This level of concern, both on the part of the KTRs and transplant professionals, is heighte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d47a1a80caeae6657b35df9385d92a8
https://pubmed.ncbi.nlm.nih.gov/32711848
https://pubmed.ncbi.nlm.nih.gov/32711848
Autor:
Christina C. Price, Frederick L. Altice, Marwan M. Azar, Dayna McManus, Shana E. Gleeson, Clemente J. Britto, Veronica Azmy, Kelsey Kaman, Matthew Davis, Geoffrey Chupp, Richard Bucala, Naftali Kaminski, Jeffrey E. Topal, Charles Dela Cruz, Maricar Malinis
Publikováno v:
Chest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a29bd50759bc3a8dcf55064af00cf32e
https://doi.org/10.1016/j.chest.2020.12.032
https://doi.org/10.1016/j.chest.2020.12.032
Publikováno v:
JAMA. 325:1558
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::211505a9f85ed68574f380295aa0f682
https://doi.org/10.1001/jama.2021.0368
https://doi.org/10.1001/jama.2021.0368
Publikováno v:
Open Forum Infectious Diseases
Background Hematopoietic stem cell transplantation (HSCT) recipients are at increased risk for non-tuberculous mycobacterial infections (NTMI), but little data exists regarding NTMI in this population. This study aimed to better define the clinical a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd894fff6929db0ae87921d8d45b3521
http://europepmc.org/articles/PMC6808976
http://europepmc.org/articles/PMC6808976
Autor:
Nora Chokr, Jeanne E. Hendrickson, Donna Summers, Stuart Seropian, Li Fang-Yong, Manoj M. Pillai, Lohith Gowda, Rory M. Shallis, Edward A. Snyder, Tae Kon Kim, Shana E. Gleeson, Iris Isufi, Wei Wei, Marwan M. Azar, Francine M. Foss, Wade L. Schulz
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S365
Introduction Blood management and infectious disease mitigation are essential for success with allogeneic stem cell transplant (alloSCT). We sought to investigate the safety profile of a proactive infection mitigation strategy with the use of pathoge
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fde4d4cae0bdfaacbc0773047954cb77
https://doi.org/10.1016/j.bbmt.2018.12.591
https://doi.org/10.1016/j.bbmt.2018.12.591